Method: LC-MS/MS (Liquid Chromatography/Tandem Mass Spectrometry) with creatinine normalization by Jaffe Reaction (CLIA 17D0919496); not cleared or approved by the FDA. Results reported in µg/g creatinine. Not a stand-alone diagnosis; should be interpreted in clinical context.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Monoisobutyl phthalate (MiBP) testing
- Di-isobutyl phthalate exposure tracking
- adhesive and personal care product chemical monitoring
What is Monoisobutyl phthalate (MiBP)?
MiBP is the primary urinary metabolite of di-isobutyl phthalate (DiBP), a plasticizer found in adhesives, sealants, and personal care products. Measured via LC-MS/MS with creatinine normalization.
Why is Monoisobutyl phthalate (MiBP) important?
DiBP shares structural and potential biological similarities with DBP-type phthalates. MiBP is commonly detected in population studies and may reflect both dietary and non-dietary exposure routes.
What insights will I get?
Your MiBP level may reflect DiBP exposure from adhesives, food contact materials, or personal care items. Tracking over time may reveal patterns tied to specific products or environments.





.avif)
.avif)
.png)

